BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao Y, Liu Q, Peng N, Li Y, Qiu D, Yang T, Kang R, Usmani A, Amadasu E, Borlongan CV, Yu G. Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer. Cell Transplant 2022;31:9636897221075749. [PMID: 35168393 DOI: 10.1177/09636897221075749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen D, Zhou X, Yan P, Yang C, Li Y, Han L, Ren X. Lipid metabolism reprogramming in colorectal cancer. J Cell Biochem 2023;124:3-16. [PMID: 36334309 DOI: 10.1002/jcb.30347] [Reference Citation Analysis]
2 Araújo D, Ribeiro E, Amorim I, Vale N. Repurposed Drugs in Gastric Cancer. Molecules 2022;28. [PMID: 36615513 DOI: 10.3390/molecules28010319] [Reference Citation Analysis]
3 Pereira M, Matuszewska K, Glogova A, Petrik J. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. Cancers 2022;14:3500. [DOI: 10.3390/cancers14143500] [Reference Citation Analysis]